Levo-Tryptophan Promotes Osteogenesis Through Calcium-Sensing Receptor

Area of Science:

• Biochemistry
• Molecular Biology
• Orthopedics

Background:

• L-Tryptophan (L-Trp) and Calcium-Sensing Receptor (CaSR) are known for their roles in bone health.
• Recent findings suggest L-Trp activates CaSR, prompting investigation into this interaction for osteogenesis.

Purpose of the Study:

• To elucidate the osteogenic mechanisms of L-Tryptophan (L-Trp) mediated by Calcium-Sensing Receptor (CaSR) activation.
• To evaluate the effects of L-Trp on mandibular bone formation and osteoblast activity in vivo and in vitro.

Main Methods:

• In vivo study: L-Trp injection into juvenile mouse temporomandibular joints, followed by Micro-CT analysis.
• In vitro study: Stimulation of MC3T3-E1 pre-osteoblasts with L-Trp, assessing proliferation, migration, and differentiation.
• Mechanism investigation: Transcriptome sequencing, qPCR, and Western blot analyses, with CaSR antagonism (NPS-2143).

Main Results:

• L-Trp injection significantly increased mandibular bone mineral density in mice.
• In vitro, L-Trp promoted pre-osteoblast proliferation, migration, differentiation, and mineralization.
• CaSR antagonism blocked L-Trp's osteogenic effects, confirming CaSR dependency.
• Transcriptome analysis identified the focal adhesion pathway (Ptk2, Rhoa, Itga11, Clec11a) as a key mediator.

Conclusions:

• L-Tryptophan (L-Trp) acts as a potent osteogenic enhancer through Calcium-Sensing Receptor (CaSR) activation.
• The focal adhesion pathway is a critical downstream mechanism for L-Trp-induced osteogenesis.
• These findings highlight L-Trp as a potential therapeutic agent for bone regeneration and related disorders.